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Abstract 
Background: Styrene and its derivatives as monomers and petroleum‑based feedstocks are valuable as raw materials 
in industrial processes. The chemical reaction for styrene production uses harsh reaction conditions such as high tem‑
peratures or pressures, or requires base catalysis with microwave heating. On the other hand, production of styrene 
and its derivatives in Escherichia coli is an environmental friendly process to produce conventional petroleum‑based 
feedstocks.
Results: An artificial biosynthetic pathway was developed in E. coli that yields 4‑hydroxystyrene, 3,4‑dihydroxysty‑
rene and 4‑hydroxy‑3‑methoxystyrene from simple carbon sources. This artificial biosynthetic pathway has a codon‑
optimized phenolic acid decarboxylase (pad) gene from Bacillus and some of the phenolic acid biosynthetic genes. E. 
coli strains with the tal and pad genes, the tal, sam5, and pad genes, and the tal, sam5, com, and pad genes produced 
4‑hydroxystyrene, 3,4‑dihydroxystyrene and 4‑hydorxy‑3‑methoxystyrene, respectively. Furthermore, these path‑
ways were expressed in a tyrosine overproducing E. coli. The yields for 4‑hydroxystyrene, 3,4‑dihydroxystyrene and 
4‑hydorxy‑3‑methoxystyrene reached 355, 63, and 64 mg/L, respectively, in shaking flasks after 36 h of cultivation.
Conclusions: Our system is the first to use E. coli with artificial biosynthetic pathways for the de novo synthesis of 
3,4‑dihydroxystyrene and 4‑hydroxy‑3‑methoxystyrene in a simple glucose medium. Similar approaches using micro‑
bial synthesis from simple sugar could be useful in the synthesis of plant‑based aromatic chemicals.
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Background
Styrene is one of the most important aromatic chemi-
cals produced industrially. It has many uses including in 
the manufacture of polystyrenes, plastics, and styrene-
butadiene rubbers. Hydroxystyrene is also a monomer 
used in the production of numerous polymers and in 
petroleum-based feedstocks for resins, elastomers, and 
adhesives. Poly-hydroxystyrene, also called polyvinylphe-
nol (PVP), is a plastic structurally similar to polystyrene. 
PVP is used in electronics as a dielectric layer in organic 
transistors of organic thin-film-transistor liquid–crystal 
display. Its ability to form linear polymers and its excel-
lent solubility in organic solvents make hydroxystyrene a 
good reagent in the chemical synthesis of various coat-
ings for electronic devices, such as a photoresist [1]. Cur-
rently, styrene production predominantly comes from 
the energy-intensive chemocatalytic dehydrogenation of 
petroleum-derived ethylbenzene [2, 3]. Because of con-
cerns over depleting feedstock availability and deleteri-
ous environmental impacts, a bio-based method could be 
a low energy, renewable alternative to petroleum-derived 
styrene [4]. Thus, an artificial pathway for styrene and 
hydroxystyrene biosynthesis from glucose in Escherichia 
coli was previously engineered [5–7]. 4-Hydroxystyrene 
is also produced in the solvent-tolerant Pseudomonas 
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putida strains, originally designed for phenol and 4-cou-
marate production [8]. In addition, styrene production in 
Saccharomyces cerevisiae was recently reported combin-
ing metabolic evolution with systematic strain and path-
way engineering [9, 10].
In recent years, several of artificial biosynthetic path-
ways have been engineered in microorganisms to pro-
duce useful, functionalized phenolic compounds from 
glucose [4, 6, 11–15]. In our laboratory, we investigate 
artificial biosynthetic pathways in microorganisms to 
produce a number of useful phenylpropanoids from 
plants [16–18]. Many of these substances in the phe-
nylpropanoid pathway is phenolic acids, e.g., cinnamic, 
4-coumaric, caffeic, ferulic, and sinapic acids. Their 
abundance has garnered much interest in their use to 
produced novel flavors, fragrances, pharmaceuticals and 
other chemicals [19].
The proposed hydroxystyrene biosynthesis pathway 
uses endogenously synthesized l-tyrosine as a precursor 
which is converted to hydroxystyrenes through a series of 
enzymatic steps shown in Figure 1. Phenolic acids, as key 
intermediates, have been previously reported for a series 
of phenolic acid biosynthetic genes characterized in E. 
coli [20]. The next step in the proposed hydroxystyrene 
biosynthesis pathway involves the subsequent decarboxy-
lation of phenolic acids by a phenolic acid decarboxylase, 
which converts these acids to their styrene derivatives 
[21–23].
This study constructed an artificial biosynthesis path-
way to produce hydroxystyrene with the tyrosine ammo-
nia lyase gene (tal) from Saccharothrix espanaensis and 
phenolic acid decarboxylase gene (pad) from Bacillus 
amyloliquefaciens. Additionally, serial artificial biosyn-
thetic gene expression sets were developed and used to 
produce 3,4-dihydroxystyrene and 4-hydorxy-3-meth-
oxystyrene by adding 4-coumarate 3-hydroxylase gene 
(sam5) and caffeic acid methyltransferase gene (com), 
respectively. Then, an E. coli strain capable of high-level 
tyrosine production was constructed with the feedback-
inhibition 3-deoxy-d-arabinoheptulosonate-7-phos-
phate (DAHP) synthase gene (aroG) and the chorismate 
mutase/prephenate dehydrogenase gene (tyrA) by modi-
fying a previously reported expression system. This 
strain was highly optimized to produce phenolic acids 
with a heavily increased metabolic flux toward l-tyros-
ine. Production of both 4-hydroxystyrene and 3,4-dihy-
droxystyrene from glucose was about 20-fold higher 
in the engineered tyrosine overproducing E. coli strain 
compared to that of the wild type E. coli. Finally, the 
yields for 4-hydroxystyrene, 3,4-dihydroxystyrene and 
4-hydorxy-3-methoxystyrene were 355, 63, and 64 mg/L, 
respectively, in shaking flasks after 36  h of cultivation. 
This is the first report of a de novo biosynthesis yielding 
3,4-dihydroxystyrene and 4-hydroxy-3-methoxystyrene 
using a single vector system combining phenolic acid bio-
synthetic genes and phenolic acid decarboxylase gene in 
Figure 1 Engineered biosynthetic pathways for hydroxystyrene derivatives starting from tyrosine in E. coli.
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E. coli. In this study, the production of 4-hydroxystyrene 
and its derivatives is accomplished with a carbohydrate 
feedstock through serial artificial biosynthetic pathways 
in E. coli strains.
Results and discussion
Bioconversion of phenolic acids to hydroxystyrenes 
through phenolic acid decarboxylase
Previous studies reported that phenolic acid decar-
boxylase from B. amyloliquefaciens produces 
4-hydroxystyrene, 3,4-dihydroxystyrene and 4-hydroxy-
3-methoxystyrene using 4-coumaric acid, caffeic acid and 
ferulic acid as substrates, respectively [21]. This study 
investigated the functions of the codon-optimized pad 
gene in E. coli in a bioconversion experiments using cin-
namic acid, 4-coumaric acid, caffeic acid, ferulic acid, 
and sinapic acid as substrates. The five phenolic acids 
were added to cultures of E. coli C41(DE3) harbor-
ing the phenolic acid decarboxylase expression vector 
(pET22-baPAD) to investigate whether phenolic acid 
decarboxylase in vivo could produce styrene derivatives 
(Figure 2). The culture broths and bacterial cells were col-
lected after 36 h of culturing, HPLC and GC/MS analy-
ses were done using the samples. In the bioconversion 
conditions, almost of the 4-coumaric acid, caffeic acid 
and ferulic acid was consumed in the culture media, 
and each hydroxystyrene was detected as a main peak 
on the HPLC profiles (Figure  3). The detailed results of 
the GC/MS analyses are presented in the additional sup-
porting section (Additional file 1: Figure  S1). When the 
bioconversion rate was calculated through a quantita-
tive comparison of the feeding substrates (2 mM) and the 
conversion ratios for 4-coumaric acid, caffeic acid, ferulic 
acid, and sinapic acid in E. coli with the pad gene were 
roughly 41, 27, 28, and 3%, respectively. In addition, the 
pad gene did not show any activity for cinnamic acid. 
These bioconversion ratios are consistent with the results 
of Jung et al. [21]. Interestingly, Jung et al. reported that 
the pad gene did not show any activity for sinapic acid. 
This study detected a 4-hydroxy-3,5-dimethoxystyrene 
peak on the HPLC profile (Figure 3D) and also confirmed 
its molecular weight with GC/MS analysis (Additional 
file 1: Figure S1). Our in vivo result for sinapic acid do not 
agree with the previously reported in vitro results. We do 
not know the reason for this, but it could be possible that 
the expressed PAD protein in E. coli affected the activity 
in vivo system. 
Construction of artificial biosynthetic pathways in E. coli 
to produce hydroxystyrene derivatives
To produce hydroxystyrene derivatives in E. coli with 
a simple sugar as a substrate, a series of plasmids were 
tal pad pET-opTD
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Figure 2 Expression vectors for the phenolic acid decarboxylase pad gene (pET22‑baPAD) and organization of the artificial gene clusters used to 
produce each hydroxystyrene derivative in E. coli. All constructs contained the T7 promoter, RBS in front of each gene, and T7 terminator at the rear 
of each gene. P PacI, S SpeI, N NdeI, H HindIII, X XhoI.
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constructed containing artificial biosynthetic pathways 
that included the pad gene (Figure  2). We previously 
reported the production of 4-coumaric acid, caffeic acid, 
and ferulic acid in E. coli harboring artificial biosynthetic 
gene clusters in which the tyrosine ammonia lyase (tal) 
and 4-coumarate 3-hydroxylase (sam5) from S. espanaen-
sis and caffeic acid methyltransferase (com) from Arabi-
dopsis thaliana [20]. The artificial biosynthetic plasmids 
containing the additional pad gene for the hydroxysty-
rene derivatives were constructed as previously described 
methods [17]. In this study, the pad gene was under the 
control of the T7 promoter. A DNA fragment contain-
ing the promoter, the pad coding region, and the termi-
nator was amplified using the pET22-baPAD plasmid as 
a template. The amplified pad fragment was ligated into 
the pET-opTAL, -opT5 and -opT5M plasmids containing 
the tal gene, the tal and sam5 genes, and the tal, sam5, 
and com genes and designated as pET-opTD, -opT5D and 
-opT5MD plasmids, respectively (Figure  2). The genes 
each have their own T7 promoter, ribosome-binding site 
(RBS), and terminator sequence same as the parental 
vector.
E. coli cells with the artificial biosynthetic pathways 
were cultured in a modified synthetic medium [24] to 
produce hydroxystyrene derivatives. The fermenta-
tion products of the E. coli strains with the tal and pad 
genes, the tal, sam5 and pad genes and tal, sam5, com, 
and pad genes had new peaks on the HPLC profiles. 
The new peak at 15.0  min from the E. coli C41(DE3) 
strain with the tal and pad genes was identical to the 
standard for 4-hydroxystyrene, and the new peak at 
9.5 min from the E. coli strain with the tal, sam5, and 
pad genes was identical to the standard for 3,4-dihy-
droxystyrene (Additional file 1: Figure  S2). Contrary 
Figure 3 Bioconversion experiments with E. coli harboring pET22‑baPAD fed with each phenolic acid. HPLC profiles of the 4‑coumaric acid (A), 
caffeic acid (B), ferulic acid (C), and sinapic acid (D) supplemented E. coli harboring pET22‑baPAD; Peak 1 4‑coumaric acid, peak 2 caffeic acid, peak 
3 ferulic acid, peak 4 sinapic acid, peak 5 4‑hydroxystyrene, peak 6 3,4‑dihydroxystyrene, peak 7 4‑hydroxy‑3‑methoxystyrene and peak 8 4‑hydroxy‑
3,5‑dimethoxystyrene.
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to our expectations, a peak for 4-hydroxy-3-methox-
ystyrene was not detected from the E. coli C41(DE3) 
strain with the tal, sam5, com, and pad genes after 
36 h of culturing. Instead, an unknown peak appeared 
at 14  min on the HPLC profile, and the area of peak 
increased over time (Additional file 1: Figure S3). The 
UV spectrum of the unknown peak did not match any 
of the styrene derivatives including 4-hydroxystyrene 
and 4-hydroxy-3-methoxystyrene. However, a peak at 
15.2  min was detected for 4-hydroxy-3-methoxysty-
rene after 2  h of culturing but disappeared after 12  h 
of culturing (Additional file 1: Figure  S3). The E. coli 
C41(DE3) strain with the tal and pad genes (pET-
opTD) yielded 17.6  ±  0.8  mg/L of 4-hydroxystyrene. 
The E. coli C41(DE3) strain with the tal, sam5, and 
pad genes (pET-opT5D) yielded 3.3  ±  0.3  mg/L of 
3,4-dihydroxystyrene (Figure 4). However, the wild 
type E. coli strain with the tal, sam5, com, and pad 
genes (pET-opT5MD) produced only a trace amount 
of 4-hydroxy-3-methoxystyrene after 2 h of culturing, 
and the product was not detected after 36 h of cultur-
ing (Figure 4).
Improved production of l‑tyrosine‑derived phenolic acids 
in a tyrosine overproducing E. coli strain
Because tyrosine serves as an immediate endogenous 
precursor to the hydroxystyrene pathway, its over pro-
duction in E. coli is essential for hydroxystyrene biosyn-
thesis. To develop a tyrosine overproducing E. coli strain, 
a classical metabolic engineering strategy was used. In 
E. coli, the aromatic amino acid biosynthesis pathway 
starts with the condensation of phosphoenolpyruvate 
and erythrose-4-phosphate, catalyzed by 3-deoxy-D-ara-
binoheptulosonate-7-phosphate (DAHP) synthase pre-
sent in three isoforms with each feedback-regulated by 
aromatic amino acids. Subsequently, l-tyrosine biosyn-
thesis from chorismate is catalyzed by the bifunctional 
enzyme chorismate mutase/prephenate dehydrogenase 
and the aromatic amino acid transaminase. Recently, 
l-tyrosine excreting E. coli strains were produced by 
deregulating the aromatic amino acid biosynthesis path-
way [20]. A high-copy number vector with feedback-
inhibition resistant (fbr) derivatives of DAHP synthase 
(aroGfbr) and chorismate mutase/prephenate dehydro-
genase (tyrAfbr) genes [25] was overexpressed in an E. 
coli ΔtyrR strain [20]. In this study, the l-tyrosine pro-
ducer, E. coli ΔCOS1, was engineered on the genome to 
also overexpress the aroGfbr and tyrAfbr genes in a ΔtyrR 
strain background. The aroGfbr and tyrAfbr gene cassette 
with a strong inducible T7 promotor was inserted into 
the tyrR gene region to make a stable strain for fermen-
tation (Additional file 1: Figures S4, S5). Overall, greater 
improvements in l-tyrosine production were achieved 
initially in wild type E. coli (Additional file 1: Figure S6). 
A maximum yield of  ~450  mg/L of l-tyrosine was pro-
duced by the E. coli ΔCOS1 strain in shaken flask experi-
ments. The tyrosine yield was comparable to the tyrosine 
overproducing E. coli strain with the aroGfbr and tyrAfbr 
gene cassette vector (400  mg/L) as previously reported 
[20]. This ΔCOS1 strain was optimized for the pro-
duction of aromatic compounds resulting in a heavily 
increased metabolic flux towards l-tyrosine. Therefore, 
it is suitable platform strain for the production of other 
l-tyrosine-derived phenolic acids including 4-coumaric 
acid, caffeic acid and ferulic acid, and hydroxystyrene 
derivatives using the phenolic acids as precursors.
Using the same experimental conditions as above, 
the tyrosine-overproducing strains acquired a substan-
tial capacity for 4-coumaric acid, caffeic acid and feru-
lic acid biosynthesis. As seen in Figure  4, the tyrosine 
overproducing E. coli ΔCOS1 strain expressing the tal 
gene (pET-opTAL) produced more than 662 ± 29 mg/L 
of 4-coumaric acid with an increase of 460% over the 
parental strain. The titers for caffeic acid did not improve 
significantly (67  ±  9  mg/L) compared to the titers for 
4-coumaric acid, despite the 478% improvement over the 
Figure 4 Production of hydroxystyrene derivatives by wild type E. 
coli strains with engineered expression vectors. The productivity of 
4‑hydroxystyrene (blue bar) and 3,4‑dihydroxystyrene (red bar) with 
pET‑opTD and pET‑opT5D in the wild type E. coli C41(DE3) strain. 
Error bars indicate standard errors of the means (n = 3). The code 
‘ND’ indicates that something was not detected in HPLC analysis. The 
production of 4‑hydroxystyrene, 3,4‑dihydroxystyrene, 4‑hydroxy‑
3‑methoxystyrene in wild type E. coli C41(DE3) were compared with 
single‑factor ANOVA (P < 0.05) using Microsoft Excel. A different letter 
code (asterisk) indicates significant difference (P = 2.38E−08).
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parental strain [20]. On the other hand, ferulic acid syn-
thesis in the ΔCOS1 strain expressing the tal, sam5, and 
com genes (pET-opT5  M) had a yield of 120 ±  3  mg/L. 
At the same time, an expected amount of accumu-
lated 4-coumaric acid and caffeic acid was also identi-
fied. In agreement with previous results [20], the titers 
for ferulic acid were also increased over caffeic acid in 
the tyrosine-overproducing strain. It is possible that 
the metabolic pathway for ferulic acid could be alleviat-
ing any restrictions for the accumulation of caffeic acid 
in the cells. Finally, almost 700 mg/L of 4-coumaric acid 
was produced. Maximum titers of 76 and 123  mg/L for 
caffeic acid and ferulic acid were achieved, respectively 
(Figure 5). Thus, the results of this study suggest that in 
a tyrosine-overproducing strain system, higher titers of 
artificial phenolic acids from the biosynthetic pathways 
mentioned above guarantee higher concentrations of 
hydroxystyrene derivatives.
Improved production of hydroxystyrene derivatives 
in tyrosine overproducing strains
Next, the fermentation products of the E. coli C41(DE3) 
strain and the tyrosine-overproducing ΔCOS1 strain 
were compared each with the tal and pad (pET-opTD), 
tal, sam5 and pad (pET-opT5D), and tal, sam5, com, 
and pad (pET-opT5MD) genes, respectively. With the 
same experimental conditions, the overproducing-
tyrosine strains had a substantial synthesis capacity for 
4-hydroxystyrene, 3,4-dihydroxystyrene and 4-hydroxy-
3-methoxystyrene. As seen in Figure  6, the ΔCOS1 
strain expressing the tal and pad genes (pET-opTD) 
produced 355  mg/L of 4-hydroxystyrene compared to 
the 17.6  mg/L produced in the C41(DE3) strain with 
the same genes. The ΔCOS1 strain expressing the tal, 
sam5 and pad genes (pET-opT5D) produced 63  mg/L 
of 3,4-dihydroxystyrene compared to the 3.3  mg/L pro-
duced in the C41(DE3) strain with the same genes. Inter-
estingly, 64  mg/L of 4-hydroxy-3-methoxystyrene was 
produced in only the ΔCOS1 strain expressing the tal, 
sam5, com, and pad genes (pET-opT5MD) with no yields 
in the C41(DE3) strain expressing the same genes after 
36 h of culturing (Figure 4). An unknown peak at 14 min 
was also detected in addition to the 4-hydroxy-3-meth-
oxystyrene peak from the ΔCOS1 strain. At the same 
time, a small amount (12 and 4  mg/L) of accumulated 
4-hydroxystyrene and 3,4-dihydroxystyrene, respectively, 
Figure 5 Production of phenolic acids by engineered tyrosine overproducing E. coli ΔCOS1 with engineered expression vectors. A HPLC profile of 
the standard 4‑coumaric acid (a), caffeic acid (b), and ferulic acid (c); the culture broth of tyrosine overproducing E. coli ΔCOS1 harboring pET‑opTAL 
(d); pET‑opT5 (e); pET‑opT5 M (f). The absorbance was monitored at 300 nm. Peak 1 4‑coumaric acid, peak 2 caffeic acid, peak 3 ferulic acid. B The 
production of 4‑coumaric acid (diagonal blue), caffeic acid (diagonal red), ferulic acid (diagonal green) with pET‑opTAL, pET‑opT5 and pET‑opT5 M 
in mutant ΔCOS1 strain. Error bars indicate standard errors of the means (n = 3). The production of 4‑coumaric acid, caffeic acid and ferulic acid in 
ΔCOS1 were compared with single‑factor ANOVA (P < 0.05) using Microsoft Excel. A different letter code (double asterisk) indicates significant differ‑
ence (P = 2.25E−08).
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was also identified in the ΔCOS1 strain expressing 
the tal, sam5, com, and pad genes (pET-opT5MD). To 
achieve higher yields of the hydroxystyrene derivatives, 
metabolite pattern analyses were performed for the tyros-
ine-overproducing ΔCOS1 strains expressing the tal and 
pad (pET-opTD), tal, sam5 and pad (pET-opT5D), and 
tal, sam5, com, and pad genes (pET-opT5MD) accord-
ing to culture times at 120, 40 and 50 h, respectively, until 
the production of each hydroxystyrene derivative was 
saturated. The amount of 4-hydroxystyrene was about 
572  mg/L at 120  h while that for 3,4-dihydroxystyrene 
and 4-hydroxy-3-methoxystyrene were about 65  mg/L 
at 40 h and 64 mg/L at 36 h, respectively (Additional file 
1: Figure  S7). The production of 4-hydroxystyrene and 
3,4-dihydroxystyrene increased by 20-fold and 21-fold 
compared to the parental strains, respectively. Further-
more, only the ΔCOS1 strain expressing the tal, sam5, 
com, and pad genes (pET-opT5MD) produced 64  mg/L 
of 4-hydroxy-3-methoxystyrene with no yields in the 
C41(DE3) strain expressing the same genes. When com-
paring the established baseline production of 4-hydrox-
ystyrene from a previously reported E. coli platform that 
used corn cobs as a renewable substrate [26, 27], the titers 
and yields achieved in this study were about 2-fold less. 
However, the titers of 4-hydroxystyrene in this study were 
achieved with a simple glucose medium as a substrate in 
culture conditions using shake flasks. The results sug-
gest that system used in this study as well as the achieved 
titers forms the basis for further improvement in the 
production of hydroxystyrene derivatives, and opens the 
possibility for a jar fermentation and extraction process. 
Furthermore, the previous report showed that the maxi-
mum concentration of 4-hydroxystyrene was limited to 
3.3 mM because of the cytotoxicity of the product to the 
E. coli host [5, 28]. To alleviate the cytotoxicity of inter-
mediates (phenolic acids) or products (hydroxystyrenes), 
a new host, such as solvent tolerant microbes, could be 
the solution for higher titers. For example, the solvent-
tolerant P. putida S12 through a two-phase fermenta-
tion had higher than 10  g/L yields of 4-hydroxystyrene 
[8]. Further, if our approach described in this manuscript 
applies to the engineering of solvent tolerant microbes, 
such as Pseudomonas and yeast platforms, higher titer 
could be achieved [8, 9]. Furthermore, a fermentation 
platform using low-priced precursor sources, such agro-
industrial wastes and lignocellulose materials [5, 27, 29], 
Figure 6 Production of hydroxystyrene derivatives by engineered tyrosine overproducing E. coli ΔCOS1 with engineered expression vectors. A 
HPLC profiles of standard 4‑hydroxystyrene (a); 3,4‑dihydroxystyrene (b); 4‑hydroxy‑3‑methoxystyrene (c); the culture broth of tyrosine overpro‑
ducing E. coli harboring pET‑opTD (d); pET‑opT5D (e); pET‑opT5MD (f). The absorbance was monitored at 259 nm. Peak 5 4‑hydroxystyrene, peak 
6 3,4‑dihydroxystyrene, peak 7 4‑hydroxy‑3‑methoxystyrene. B The productivity of 4‑hydroxystyrene (blue bar), 3,4‑dihydroxystyrene (red bar), and 
4‑hydroxy‑3‑methoxystyrene (green bar) with pET‑opTD, pET‑opT5D, and pET‑opT5MD in ΔCOS1 strain. Error bars indicate standard errors of the 
means (n = 3). The production of 4‑hydroxystyrene, 3,4‑dihydroxystyrene, 4‑hydroxy‑3‑methoxystyrene in ΔCOS1 were compared with single‑
factor ANOVA (P < 0.05) using Microsoft Excel. A different letter code (triple asterisk) indicates significant difference (P = 5.66E−11).
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could be what is needed for the substantial and economi-
cal production of hydroxystyrene monomers, which are 
presently produced from non-renewable petroleum.
Conclusions
The system in this study converts 4-coumaric acid to 
4-hydroxystyrene through pad (phenolic acid decarboxy-
lase), which is eventually converted caffeic acid and ferulic 
acid and then to 3,4-dihydroxystyrene and 4-hydorxy-
3-methoxystyrene, respectively. E. coli strains express-
ing tal (tyrosine ammonia lyase) and pad, and tal, sam5 
(4-coumarate 3-hydroxylase), and pad, and tal, sam5, 
com (caffeic acid methyltransferase), and pad produced 
4-hydroxystyrene, 3, 4-dihydroxystyrene and 4-hydroxy-
3-methoxystyrene, respectively, using a simple sugar 
medium without precursor feeding. Furthermore, these 
pathways were extended in an E. coli strain with the bio-
synthesis machinery for overproducing tyrosine. Finally, 
the titers for 4-hydroxystyrene, 3,4-dihydroxystyrene and 
4-hydroxy-3-methoxystyrene in the tyrosine-overproduc-
ing E. coli strains reached 355, 63, and 64 mg/L, respec-
tively, in shaking flasks after 36 h of cultivation.
Methods
Bacterial strains, plasmids, and chemicals
The strains and plasmids used in this study are listed in 
Table 1. Antibiotics were added to the medium as required 
at the following concentrations: ampicillin, 100  mg/L; 
kanamycin, 50 mg/L; and tetracycline, 10 mg/L. Cinnamic 
acid, 4-coumaric acid, caffeic acid, ferulic acid, sinapic acid, 
4-hydroxystyrene (4-vinylphenol), and 4-hydroxy-3-meth-
oxystyrene (2-methoxy-4-vinylphenol) were purchased 
from Sigma–Aldrich (USA), and 3,4-dihydroxystyrene was 
purchased from Toronto Research Chemicals Inc. (Canada) 
as a standard for compound identification by HPLC.
DNA manipulation
The restriction enzymes (NEB; Takara), Ex Taq polymer-
ase (Takara), pfu Taq polymerase (Enzynomics, Korea), 
an AccuPower Ligation kit (Bioneer, Korea), and a Quick 
& Easy E. coli gene deletion kit (Gene Bridges, German) 
were used according to the manufacturers’ instructions. 
The optimized tyrosine ammonia lyase gene (tal) and 
4-coumarate 3-hydroxylase gene (sam5) from S. espa-
naensis and the caffeic acid methyltransferase gene (com) 
from A. thaliana were synthesized previously by DNA 
2.0 [20]. Codon optimization and synthesis of the phe-
nolic acid decarboxylase gene (pad) from B. amylolique-
faciens DSM7 (GenBank FN597644) were performed 
with the GeneGPS™ program (DNA2.0).
Construction of phenolic acid decarboxylase expression 
vectors and assembly of the artificial biosynthetic 
pathways
In order to construct an expression vector containing the 
phenolic acid decarboxylase gene (pad) that was under 
Table 1 Plasmids and strains used in this study
Plasmid or strain Relevant characteristics Source
Plasmid
 pET‑22b(+) f1 ori, T7 promoter, AmpR Novagen
 pET‑28a(+) f1 ori, T7 promoter, KanR Novagen
 pET‑opTAL pET‑28a(+) carrying codon‑optimized tyrosine ammonia lyase gene (tal) Kang et al. [20]
 pET‑Sam5 pET‑28a(+) carrying 4‑coumarate 3‑hydroxylase gene (sam5) Choi et al. [17]
 pET‑COM pET‑28a(+) carrying caffeic acid methyltransferase gene (com) Choi et al. [17]
 pET‑opT5 pET‑28a(+) carrying tal and sam5 gene Kang et al. [20]
 pET‑opT5M pET‑28a(+) carrying tal, sam5, and com gene Kang et al. [20]
 pET28‑tyrA* pET‑28a(+) carrying feedback‑inhibition resistant chorismate mutase/prephenate dehydrogenase gene 
(tyrAfbr)
Kang et al. [20]
 pET22‑aroG* pET‑22b(+) carrying feedback‑inhibition resistant DAHP synthase gene (aroGfbr) Kang et al. [20]
 pET‑AG pET‑28a(+) carrying tyrAfbr and aroGfbr gene This study
 pET22‑baPAD pET‑22b(+) carrying codon‑optimized phenolic acid decarboxylase gene (pad) This study
 pET‑opTD pET‑28a(+) carrying tal and pad gene This study
 pET‑opT5D pET‑28a(+) carrying tal, sam5 and pad gene This study
 pET‑opT5MD pET‑28a(+) carrying tal, sam5, com and pad gene This study
Strain
 E. coli DH5α Cloning host Invitrogen
 E. coli C41(DE3) Derivative strain of E. coli BL21(DE3) Miroux and Walker [31]
 ΔtyrR tryR gene in‑frame deletion mutant of E. coli C41(DE3) Kang et al. [20]
 ΔCOS1 E. coli C41(DE3); ΔtyrR::tyrAfbr, aroGfbr; tyrosine overproducing strain This study
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the control of independent T7 promoter, a 0.5-kb DNA 
fragment, which contained the synthetic pad coding 
region, was cloned into the NdeI and XhoI sites on pET-
22b(+), which resulted in pET22-baPAD. The three genes 
(tal, sam5, and com) were independently cloned into 
pET-22b(+) or pET-28a(+) vectors [17, 20]. Using the 
tal, sam5, com, and pad genes as templates, four DNA 
fragments were amplified by PCR with the appropri-
ate pairs of primers. In order to assemble the pET-opTD 
vector, the tal coding region was amplified using pET-
opTAL as a template with the primer opTAL-F (5′-CAT 
ATGACCCAGGTGGTTGAACGCC-3′) and Cpac (the 
sequence is located downstream of the T7 terminator 
region of the pET vector and contains the designed PacI 
site: TTAATTAATGCGCCGCTACAGGGCGCGTCC), 
also the pad coding region was amplified using pET22-
baPAD as a template with the primer Npac (the sequence 
is located upstream of the T7 promoter region of the 
pET vector and contains the designed PacI site: TTAAT 
TAATCGCCGCGACAATTTGCGACGG) and baPAD-R 
(the sequence contains the designed XhoI site 5′-CTC 
GAGTTACTTCAGTTTACC-3′). Each of the amplified 
fragments were digested with corresponding sites and 
cloned between the NdeI and XhoI digested pET-28a(+) 
via ligation, which resulted in pET-opTD. A 2.5-kb PacI 
fragment containing the sam5 gene was PCR-amplified 
with the NPac and CPac primers using pET22-Sam5 as 
a template. The amplified fragment was digested with 
PacI and cloned between the PacI digested pET-opTD, 
which resulted in pET-opT5D. Finally, a 2.5-kb PacI/SpeI 
fragment containing the com gene was PCR-amplified 
with the NPac and Cspe (the sequence is located down-
stream of the T7 terminator region of the pET vector 
and contains the designed SpeI site: ACTAGTTCCTC-
CTTTCAGCAAAAAACCCCTC) primers using pET22-
COM as a template. A 2.5-kb PacI fragment containing 
the sam5 gene was PCR-amplified with the NPac and 
CPac primers using pET22- Sam5 as a template. Each of 
the two amplified fragments were digested with corre-
sponding sites and cloned into PacI digested pET-opTD, 
which resulted in pET-opT5MD (Figure 2).
Construction of the l‑tyrosine overproducing strain
An l-tyrosine over-producing strain of E. coli (ΔCOS1) 
was achieved by extra gene insertion of aroG and tyrA, 
feedback-inhibition resistance (fbr) genes on the tyrR 
gene locus. The genetic design of the aroG and tyrA 
feedback-inhibition resistance (fbr) genes was followed 
as previously described by Lütke-Eversloh and Stepha-
nopoulos [25, 30] and used our previously made con-
structs [20]. The PCR product was generated using the 
tyrAfbr-aroGfbr-FRT-neo-FRT fragment as a template for 
pET-AG and FRT-neo-FRT fragment (Gene Bridges). We 
made a fragment containing both the tyrAfbr and aroGfbr 
gene cassette, in which the RBS and T7 promoter were 




GCGCGTAACCACCACACCCGC CGCGCT-3′), and 





These two fragments were connected between the SpeI 
site of pUC19 using the In-fusion kit (Clontech Labo-
ratories, Inc., USA), resulting in pUC-AGFRT (Addi-
tional file 1: Figure  S4). The 5.9-kb insertion PCR 
product was generated using pUC-AGFRT as a tem-
plate and the following primers, tyrRr (5′-ATCAGGCAT 
ATTCGCGCTTACTCTT CGTTCTTCTTCTGACTCA 
GACCATATAATACGACTCACTATAGGGCTC-3′) 
and Inf-tryRfAG (5′-GTCATATCATCATATTAATT 
GTTCTTTTTTCAGGTGAAGGTTCCCATGC GTAC 
TAGTCGTTCTACCATCGACACC-3′), and this gene 
cassette was inserted between the tyrR gene for gene 
insertional inactivation, which was done as previously 
reported using RED/ET recombination with a Quick & 
Easy E. coli Gene deletion kit (Gene Bridges). The clones 
growing on the kanamycin plate still contained the selec-
tion marker cassette, while all other clones containing 
insertional inactivation lost the selection marker. The 
kanamycin selection marker was removed from the chro-
mosome by transforming the cells with an FLP recombi-
nase expression plasmid, 707-FLPe (Gene Bridges). The 
insertional inactivation mutant (ΔCOS1) was verified 
through PCR using the following primers: tyrA-F (5′- 
CCATGGTTGCTGAATTGACCGCATTACG-3′) and 
aroG-R (5′- AAGCTTAACCACGA CGCGCTTTCA 
CAGC-3′). The PCR product was sequenced and verified 
(Additional file 1: Figure S5).
Culture conditions for production
Recombinant E. coli C41 (DE3) strains [31] harboring 
plasmids were grown at 37°C in a Luria–Bertani (LB) 
medium containing 50 μg/mL kanamycin. The overnight 
culture was inoculated (1.5%) into fresh LB medium 
supplemented with the same concentration of kanamy-
cin. The culture was grown at 37°C to an optical density 
at 600  nm (OD600) of 0.6, and IPTG was added to the 
final concentration of 1  mM, and the culture was incu-
bated for 6 h. The cells were harvested by centrifugation, 
suspended, and incubated at 26°C for 36  h in a modi-
fied synthetic medium (3 g/L KH2PO4, 7.3 g/L K2HPO4, 
8.4 g/L MOPS, 2 g/L NH4Cl, 0.5 g/L NaCl, 0.1 ml/L Trace 
Page 10 of 11Kang et al. Microb Cell Fact  (2015) 14:78 
elements, 5  g/L (NH4)2SO4, 5  g/L MgSO4, and supple-
mented with 15 g/L glucose, 1 mM IPTG and appropriate 
antibiotics) [24]. For the feeding experiments, the cul-
tures were supplemented with cinnamic acid, 4-coumaric 
acid, caffeic acid, ferulic acid, or sinapic acid (final con-
centration: 2  mM), respectively. The samples were col-
lected after 36 h and analyzed by HPLC.
Detection and quantification of the products
To quantify 4-hydroxystyrene, 3,4-dihydroxystyrene and 
4-hydroxy-3-methoxystyrene, 1  mL of cell-free culture 
supernatants was filtered through a 0.2  μm cellulose 
membrane syringe filter (Sartorius) and used for HPLC 
analysis with a Dionex Separations module connected 
with a Photodiode Array detector (Dionex) set. Twenty 
microliters of the samples were applied to a J’sphere ODS-
H80 column (4.6 ×  150  mm i.d., 5 μm; YMC, Japan) in 
a high-performance liquid chromatography (HPLC) sys-
tem [CH3CN-H2O (0.05% trifluoroacetic acid), 20–60% 
acetonitrile (CH3CN) for 25 min at flow rate of 1 mL/min; 
Dionex, USA] equipped with a photodiode array detector. 
Quantification of the three above-mentioned compounds 
was based on the peak areas of absorbance at 259  nm. 
Purchased 3,4-dihydroxystyrene and 4-hydroxy-3-meth-
oxystyrene as a standard contains the impurity. There-
fore, all the hydroxystyrene derivatives were measured 
as equivalent to 4-hydroxystyrene. For the quantifica-
tion of 4-coumaric acid, caffeic acid, and ferulic acid, the 
HPLC analysis was followed as our previously described 
methods [20]. The data shown in this study were gener-
ated from triplicate independent experiments. The titers 
for each production were compared with single-factor 
ANOVA (P < 0.05) using the single-factor ANOVA tool.
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